Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP460653.RA2JvBn-oq-0FXLvNieK1nAn6NM0pYbVgF7xfHC6PIF6E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP460653.RA2JvBn-oq-0FXLvNieK1nAn6NM0pYbVgF7xfHC6PIF6E130_assertion type Assertion NP460653.RA2JvBn-oq-0FXLvNieK1nAn6NM0pYbVgF7xfHC6PIF6E130_head.
- NP460653.RA2JvBn-oq-0FXLvNieK1nAn6NM0pYbVgF7xfHC6PIF6E130_assertion description "[In the multivariate logistic regression models, CTLA4 +49 A/G variant genotype was associated with increased risk (AA vs GG) by 1.43-fold (95% CI = 0.94-2.17) for HCC, and 1.66-fold (95% CI = 1.13-2.44) for cervical cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP460653.RA2JvBn-oq-0FXLvNieK1nAn6NM0pYbVgF7xfHC6PIF6E130_provenance.
- NP460653.RA2JvBn-oq-0FXLvNieK1nAn6NM0pYbVgF7xfHC6PIF6E130_assertion evidence source_evidence_literature NP460653.RA2JvBn-oq-0FXLvNieK1nAn6NM0pYbVgF7xfHC6PIF6E130_provenance.
- NP460653.RA2JvBn-oq-0FXLvNieK1nAn6NM0pYbVgF7xfHC6PIF6E130_assertion SIO_000772 20538028 NP460653.RA2JvBn-oq-0FXLvNieK1nAn6NM0pYbVgF7xfHC6PIF6E130_provenance.
- NP460653.RA2JvBn-oq-0FXLvNieK1nAn6NM0pYbVgF7xfHC6PIF6E130_assertion wasDerivedFrom befree-20140225 NP460653.RA2JvBn-oq-0FXLvNieK1nAn6NM0pYbVgF7xfHC6PIF6E130_provenance.
- NP460653.RA2JvBn-oq-0FXLvNieK1nAn6NM0pYbVgF7xfHC6PIF6E130_assertion wasGeneratedBy ECO_0000203 NP460653.RA2JvBn-oq-0FXLvNieK1nAn6NM0pYbVgF7xfHC6PIF6E130_provenance.